CVS Caremark Corporation Settles U.S. Investigation, To Pay $5 Million-Reuters

Reuters reported that CVS Caremark Corporation agreed to pay $5 million to settle charges of inaccurate pricing of some drugs for the elderly and the disabled, ending a wide ranging, multi year probe into its business practices. The Federal Trade Commission said RxAmerica, which CVS bought in 2008, had posted incorrect prices online for some Medicare Part D prescription drugs sold at CVS and Walgreen Co stores. In some cases, the real prices were 10 times higher than those posted, the FTC said. The $5 million will be used to reimburse seniors who overpaid, the FTC said in a